Hypertension and cardiovascular risk reduction in African Americans: a roundtable discussion.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D044383:Black People; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000208:ethnology* / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000208:ethnology; D006333:Heart Failure / Q000188:drug therapy / Q000208:ethnology; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy / Q000208:ethnology*; D015995:Prevalence; D051437:Renal Insufficiency / Q000150:complications* / Q000208:ethnology / Q000517:prevention & control; D012307:Risk Factors; D040242:Risk Reduction Behavior; D020521:Stroke / Q000188:drug therapy / Q000208:ethnology; D014481:United States / Q000453:epidemiology; D001741:Black or African American
D000806:Angiotensin-Converting Enzyme Inhibitors